Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01413009 · ClinicalTrials.gov registry record
Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol
A clinical trial of ICU Delirium and Immobility, sponsored by University of Nebraska.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT01413009 is a study of ICU Delirium and Immobility that has completed, run by University of Nebraska. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01413009, a study of ICU Delirium and Immobility, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Fully two-thirds of ICU patients develop delirium, which is associated with longer stays, billions of dollars in costs globally, and 3-fold excess mortality at 6 months. Over one-half of ICU survivors suffer a functionally debilitating dementia-like illness, which appears related to delirium duration. This study will focus on applying Awakening-Breathing Coordination, Delirium Monitoring/Management \& Early Mobility (ABCDE), a program of delirium screening, prevention, and treatment developed at Vanderbilt University. Specifically, the study will implement the ABCDE program in a medical center that does not currently perform routine ICU delirium screenings and identify facilitators and barriers to program adoption; test the impact of the ABCDE program on patient outcomes, nursing quality outcomes, and system outcomes; and assess the extent to which ABCDE implementation is effective, sustainable, and conducive to dissemination into other settings.
Conditions Studied
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2010-12-29 |
| Est. Completion | 2013-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01413009
The ClinicalTrials.gov registry entry for NCT01413009 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with ICU Delirium appearing as the primary indexed condition, and to 0 interventions.
NCT01413009 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT01413009 about?
NCT01413009 is a clinical study titled "Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol". Fully two-thirds of ICU patients develop delirium, which is associated with longer stays, billions of dollars in costs globally, and 3-fold excess mortality at 6 months. Over one-half of ICU survivors suffer a functionally debilitating dementia-like illness, which appears related to delirium duratio...
What is the current status of trial NCT01413009?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2010-12-29. Estimated completion is 2013-06-01.
What conditions does trial NCT01413009 study?
This clinical trial studies the following conditions: ICU Delirium, Immobility.
Who is sponsoring clinical trial NCT01413009?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01413009 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ICU Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.